Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Compulsivity in At-Risk Eating Disorder Population
NCT02794389Completed
- Sponsor
- University of Oxford
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing N-acetyl cysteine with Placebo (2 arms). Primary endpoint: Berg Card-Sort Task Score at Day 9. Started Mar 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT02794389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794389.